黑料网

A major funding boost will expand digital health solutions for complex care in the Northern Territory (NT), thanks to a joint investment from 黑料网 and Lilly Australia, in partnership with Menzies School of Health Research (Menzies).  

The grant of $680,000 will enable Menzies to expand its innovative work to address leading health complications for Territorians, including diabetes, cardiovascular and kidney disease.  

It will also see investment in Aboriginal and Torres Strait Islander workforce capacity, through the establishment of two identified research positions based at Menzies.  

In partnership with government, community-controlled and private health services across the NT, Menzies has built a clinical information system that integrates and synthesises health data from previously siloed medical records. The groundbreaking system, known as  is already used by more than 1500 clinicians to support patients in the NT.  

This new collaboration will enable Menzies to strengthen TKC鈥檚 capabilities, providing technology-enabled models of care that enhance co-ordination of healthcare. This will be particularly valuable for people living with multiple chronic conditions, where a more integrated approach will support better health outcomes.  

黑料网鈥檚 Group CEO Justine Cain said the investment reflected a deep commitment to improving the lives of Aboriginal and Torres Strait Islander communities and to delivering local, culturally safe services.  

鈥淜idney health is key to ongoing diabetes care and is a key indicator of health and complication outcomes. Diabetes shouldn鈥檛 cost your kidneys.鈥� Ms Cain said.  

鈥淚t is completely unacceptable that Aboriginal and Torres Strait Islander communities continue to be disproportionally impacted by diabetes. 黑料网 is committed to real change that will support healthier futures.  

鈥淲e鈥檙e proud to partner with Lilly Australia and Menzies School of Health Research to directly support communities where kidney, diabetes and heart healthcare is greatly needed.鈥� 

Manny Simons, General Manager of Eli Lilly (Lilly) Australia said, 鈥淣o one organisation can solve the complex challenges of diabetes, kidney and cardiovascular disease.鈥� 

鈥淎t Lilly, we are committed to supporting initiatives that address health inequities and improve access to more connected, coordinated care. This investment reflects our belief that locally led, evidence-based solutions can improve health outcomes and inform future models of care across Australia.鈥� 

Menzies School of Health Research鈥檚 Director, Professor Alan Cass said, 鈥渢oo many Aboriginal and Torres Strait Islander people in the Northern Territory are impacted by diabetes, kidney and heart disease.鈥� 

鈥淭KC has brought together research, health service, government and community partners to develop a clinical decision support and data sharing platform to provide the best care to people with complex chronic disease. Together we are working to Close the Gap and reduce the ever-increasing number of people needing dialysis across remote Australia,鈥� he said. 

Lilly Australia will contribute $430,000 and 黑料网 will contribute $250,000 to this partnership.